# EDGAR Filing Document

**Accession Number:** 0001715579
**File Stem:** 0001021408-25-000905
**Filing Date:** 2025-8
**Character Count:** 6293
**Document Hash:** 148c0251f3fee7684cd68d9d191e074f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001021408-25-000905.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001021408-25-000905

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250805

**EFFECTIVENESS DATE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medicxi Ventures Management (Jersey) Ltd
- **CENTRAL INDEX KEY:** 0001715579

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Y9

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-19833
- **FILM NUMBER:** 251183812

**BUSINESS ADDRESS:**
- **STREET 1:** C/O CSC FUND SERVICES (JERSEY) LIMITED
- **STREET 2:** 44 ESPLANADE
- **CITY:** ST. HELIER
- **STATE:** Y9
- **ZIP:** JE4 9WG
- **BUSINESS PHONE:** 44 (0) 1534 504343

**MAIL ADDRESS:**
- **STREET 1:** C/O CSC FUND SERVICES (JERSEY) LIMITED
- **STREET 2:** 44 ESPLANADE
- **CITY:** ST. HELIER
- **STATE:** Y9
- **ZIP:** JE4 9WG

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001715579

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Medicxi Ventures Management (Jersey) Ltd

**Address:** C/O CSC  FUND SERVICES (JERSEY), ST. HELIER, Y9 JE4 9WG

**Telephone number:** 44 1534 481050

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-19833

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 1

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER               | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| CENTESSA PHARMACEUTICALS PLC | 152309100 | 06/20/2025     | To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the proxy statement. | SECTION 14A SAY-ON-PAY VOTES |       19963157 |                0 | FOR         |                                 19963157 | FOR                         |  |
| NEWAMSTERDAM PHARMA COMPANY  | N62509109 | 06/04/2025     | Non-binding, advisory vote to approve the 2024 compensation of named executive officers.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        2869565 |                0 | FOR         |                                  2869565 | FOR                         |  |
| NEWAMSTERDAM PHARMA COMPANY  | N62509109 | 06/04/2025     | Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.                                                                          | SECTION 14A SAY-ON-PAY VOTES |        2869565 |                0 | 1 YEAR      |                                  2869565 | FOR                         |  |
| PHATHOM PHARMACEUTICALS INC  | 71722W107 | 06/03/2025     | To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay").                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        7464572 |                0 | FOR         |                                  7464572 | FOR                         |  |
| PHATHOM PHARMACEUTICALS INC  | 71722W107 | 06/03/2025     | To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency").                                                          | SECTION 14A SAY-ON-PAY VOTES |        7464572 |                0 | 1 YEAR      |                                  7464572 | FOR                         |  |
| RAPT THERAPEUTICS INC        | 75382E208 | 05/29/2025     | To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s named executive ofﬁcers.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |       22352000 |                0 | FOR         |                                 22352000 | FOR                         |  |
| RAPT THERAPEUTICS INC        | 75382E208 | 05/29/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of RAPT Therapeutics, Inc.'s named executive ofﬁcers.                                              | SECTION 14A SAY-ON-PAY VOTES |       22352000 |                0 | 1 YEAR      |                                 22352000 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Medicxi Ventures Management (Jersey) Ltd

**By (Signature):** Giles Johnstone-Scott

**By (Printed Signature):** Giles Johnstone-Scott

**By (Title):** Director

**Date:** 08/04/2025